For pharmacy leaders evaluating containment strategies for non-sterile hazardous drug handling, the NuAire LabGard CVE NU-813 offers a focused solution aligned with USP <800> requirements. As a Class I containment ventilated enclosure, it is designed specifically for powder and aerosol control, supporting workflows such as hazardous drug compounding, chemical weighing, and analytical preparation. Its HEPA-filtered negative-pressure airflow helps protect personnel by preventing contaminant escape, while real-time airflow monitoring through Aeromax provides operational visibility that supports compliance readiness and internal quality assurance.
The NU-813’s design reflects practical considerations for pharmacy environments where space, flexibility, and workflow integration matter. Available in multiple bench sizes with optional mobility features, it can be adapted to different facility layouts without requiring major infrastructure changes. Configuration options such as single or redundant exhaust HEPA filtration allow pharmacies to align the unit with their ventilation strategy, whether ducted or recirculating. Additional features like cord pass-throughs, ergonomic airfoils, and optional accessories support efficient daily use without introducing unnecessary complexity.
From an operational perspective, the NU-813 contributes to both safety and efficiency. The bag-in and bag-out filter change system reduces exposure risk during maintenance, which is an important consideration for staff safety and certification processes. For decision-makers, this type of containment solution supports a balance among regulatory compliance, workforce protection, and workflow continuity, particularly in settings that manage oncology-related powders or other hazardous compounds.
